Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

A 2023 reform has boosted voucher use by 67%, with one-quarter of state scholarships now going to families in the top income ...

Rupert’s shocking decision was the climax of a succession battle that had pitted James and Lachlan, born just 15 months apart ...

Ford's first visit to the museum as a child in a racially divided city wasn't all that welcoming, but a lot has changed in ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

At the National Museum of African Art, a Washington, D.C. artist’s work illuminates a gallery room and honors 54 people who ...

Showtime's Yellowjackets returns for a third season where the seasons may have changed, but tensions between the women are as ...